124 related articles for article (PubMed ID: 30728210)
21. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
22. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
[TBL] [Abstract][Full Text] [Related]
23. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
[TBL] [Abstract][Full Text] [Related]
24. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
[TBL] [Abstract][Full Text] [Related]
25. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation.
Mao H; Pan F; Wu Z; Wang Z; Zhou Y; Zhang P; Gou M; Dai G
Int Immunopharmacol; 2017 Aug; 49():95-101. PubMed ID: 28558303
[TBL] [Abstract][Full Text] [Related]
26. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
[TBL] [Abstract][Full Text] [Related]
27. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
Gai XD; Song Y; Li C; Lei YM; Yang B
Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
[No Abstract] [Full Text] [Related]
29. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.
Adurthi S; Mukherjee G; Krishnamurthy H; Sudhir K; Bafna UD; Umadevi K; Jayshree RS
Int J Gynecol Cancer; 2012 Sep; 22(7):1130-7. PubMed ID: 22872166
[TBL] [Abstract][Full Text] [Related]
30. MiR-21 controls in situ expansion of CCR6⁺ regulatory T cells through PTEN/AKT pathway in breast cancer.
Hu Y; Wang C; Li Y; Zhao J; Chen C; Zhou Y; Tao Y; Guo M; Qin N; Ren T; Wen Z; Xu L
Immunol Cell Biol; 2015 Sep; 93(8):753-64. PubMed ID: 25735723
[TBL] [Abstract][Full Text] [Related]
31. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.
Fantini MC; Favale A; Onali S; Facciotti F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937953
[TBL] [Abstract][Full Text] [Related]
32. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
33. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
34. FOXP3 and CD25 double staining antibody cocktails identify regulatory T cells in different types of tumor tissues using tissue microarrays.
Liu X; Wang X; Ding J; Gao Y; Zhao Y; Zhao R; Sun Q; Zhang S
Ann Diagn Pathol; 2019 Feb; 38():67-70. PubMed ID: 30502715
[TBL] [Abstract][Full Text] [Related]
35. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
[TBL] [Abstract][Full Text] [Related]
36. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
37. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
[TBL] [Abstract][Full Text] [Related]
38. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.
Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson S; Landay A; Solomon M; Selby W; Alexander SI; Nanan R; Kelleher A; Fazekas de St Groth B
J Exp Med; 2006 Jul; 203(7):1693-700. PubMed ID: 16818676
[TBL] [Abstract][Full Text] [Related]
39. Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells.
Wang Q; Feng M; Yu T; Liu X; Zhang P
Cell Immunol; 2014 Feb; 287(2):100-5. PubMed ID: 24487033
[TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
